arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ATOSSA THERAPEUTICS, INC.

ATOS

$1.99 ▼ -0.13 (-6.13%) at close

18 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

ATOSSA THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $17.1M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -94.4% ↘

FCF / Share $-3.46 ↘

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.76K

↓ -99.7% —

Net Income Profit after all expenses

$-34.77M

↓ -36.3% —

FCF / Share Free cash flow per share

$-3.46

↓ -37.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	-99.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1346%)	-16.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-311%)	31.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+291%)	32022.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+400185%)	—	—	—	—
EPS Growth YoY (%)	-32.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	15.1% Good Good Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-36.3% Weak ↓ Weak Declining Year-over-year change in net income	15.3% Good ↑ Good Improving Year-over-year change in net income	-11.6% Weak ↑ Weak Improving Year-over-year change in net income	-30.8% Weak ↓ Weak Declining Year-over-year change in net income	-15.6% Weak ↑ Weak Improving Year-over-year change in net income	-3.4% Weak ↑ Weak Improving Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	-40.4% Weak ↓ Weak Declining Year-over-year change in net income	-27.5% Weak ↓ Weak Declining Year-over-year change in net income	59.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-7.5% Weak ↑ Weak Improving Year-over-year change in net income	-35.9% Weak ↑ Weak Improving Year-over-year change in net income	-112.3% Weak ↑ Weak Improving Year-over-year change in net income	-47.6% Weak Weak Year-over-year change in net income	-216.7% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	-37.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	-1.1% Weak Weak Year-over-year change in free cash flow	-1.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	-84.6% Weak Weak Compound annual revenue growth over 3 years	605.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Return on Invested Capital (%)	-94.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-131.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-129.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-110.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-203.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-269.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-121.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-80.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-77.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-173.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-78.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-119.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-97.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-93.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-192.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-204.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-124.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-74.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-111.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-88.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-689%)	-35.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-338%)	-33.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-320%)	-22.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-14.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-65.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-537%)	-131.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-974%)	-129.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-964%)	-117.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-880%)	-205.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1471%)	—	-154.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1129%)	-101.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-778%)	-98.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-754%)	-220.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1571%)	127.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+751%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	-23179.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-928.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-29957.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-421.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	-190.60x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-41.30M	$-71.08M	$-88.46M	$-110.89M	$-136.38M	$-39.55M	$-12.58M	$-10.38M	$-7.22M	$-3.03M	$-3.72M	$-8.50M	$-6.34M	$-1.73M	$-1.91M	$-10.25K	—	$0.00

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Basic EPS, GAAP (USD)	$-4.04	$-3.04	$-3.58	$-3.13	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.46	$-2.51	$-2.48	$-2.45	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.57	$8.30	$10.84	$13.90	$16.28	$8.53	$21.50	$22.48	$39.05	$12.21	$25.65	$5.77	$8.52	$5.98	$2.07	—	—	—
Tangible Book Value per Share (USD)	$4.57	$8.30	$10.84	$13.90	$16.28	$8.51	$21.22	$21.99	$37.73	$12.21	$25.65	$5.77	$8.52	$5.98	$2.07	—	—	—
Basic Weighted Avg Shares (shares)	8.61M	8.39M	8.45M	8.48M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Working Capital (USD)	$37.36M	$69.49M	$86.98M	$112.63M	$138.11M	$27.10M	$13.00M	$8.63M	$6.67M	$2.21M	$1.79M	$6.87M	$5.36M	$338.90K	$1.43M	—	—	—
Total Equity (USD)	$39.35M	$71.48M	$91.02M	$117.96M	$138.14M	$27.17M	$13.16M	$8.81M	$6.94M	$3.10M	$3.74M	$9.50M	$10.60M	$5.18M	$1.56M	$-851.85K	$31.68K	$54.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Apr 30, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	$1.76K	$525.95K	$632.56K	$481.84K	$1.50K	—	—	—
Depreciation Expense (USD)	$16.00K	$17.00K	$23.00K	$8.00K	$23.00K	$47.00K	$52.79K	$44.20K	$128.99K	$303.48K	$272.63K	$564.46K	$472.93K	$130.55K	$15.62K	—	—	—
Net Income, GAAP (USD)	$-34.77M	$-25.50M	$-30.09M	$-26.96M	$-20.61M	$-17.83M	$-17.24M	$-11.40M	$-8.12M	$-6.37M	$-15.76M	$-14.66M	$-10.78M	$-5.08M	$-3.44M	$-1.09M	—	—
Operating Cash Flow (USD)	$-29.76M	$-21.03M	$-20.94M	$-20.76M	$-16.47M	$-11.57M	$-9.13M	$-8.96M	$-6.59M	$-5.37M	$-13.95M	—	—	—	$-3.49M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 63 quarters

ATOSSA THERAPEUTICS, INC.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ATOS with peers